Plain-English translation of NCT05837767 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new way to deliver radiation therapy called lattice radiation therapy (LRT) for patients with advanced cancers that have spread beyond their original site. Researchers want to see if this new radiation pattern works better than the standard approach and whether it helps your body's immune system fight cancer cells more effectively.
Standard radiation therapy has limitations for treating cancer that has spread to multiple sites in the body. This trial explores whether a new radiation pattern could improve outcomes and boost your immune system's ability to attack cancer cells.
You likely qualify if…
You likely don't qualify if…
You would receive the new lattice radiation therapy treatment to at least one of your cancer sites, while other sites could be treated with standard radiation if needed. The study team will monitor how well the treatment works and how it affects your immune system through imaging scans and blood tests over the course of your participation.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States